...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Endovascular stent placement for angioplasty-induced venous rupture related to the treatment of hemodialysis grafts.
【24h】

Endovascular stent placement for angioplasty-induced venous rupture related to the treatment of hemodialysis grafts.

机译:血管内支架置入术用于血管成形术诱发的静脉破裂,与血液透析移植物的治疗有关。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To assess the use of endovascular stents for treating rupture after percutaneous transluminal angioplasty (PTA) in the maintenance of hemodialysis grafts. MATERIALS AND METHODS: From February 1, 1994, to August 1, 1997, 683 hemodialysis-related angioplasty procedures were performed on 277 patients to treat thrombosed or poorly functioning polytetrafluoroethylene (PTFE) hemodialysis bridge grafts. In each of these procedures, angioplasty of the venous anastomosis or the outflow vein was performed. This study is a retrospective review to analyze uncovered endovascular stents placed to treat ruptures after PTA. RESULTS: Fourteen ruptures were treated with use of an uncovered metal stent. Stent placement was technically successful in 11 of 14 patients, with clinical success in 11 of 14 cases. The primary patencies at 30, 60, 90, and 120 days were calculated by means of Kaplan-Meier life-table analysis; these were 63%, 54%, 46%, and 46%, respectively. The secondary patencies at 60, 120, and 180 days were 85%, 75%, and 75%, respectively. No complications were attributable to stent placement. The results are comparable to those of stents placed for reasons other than rupture, and support the efficacy of their use for this indication. CONCLUSION: Endovascular stent placement is a safe and effective means of salvaging angioplasty-induced rupture that occurs during the treatment of hemodialysis grafts.
机译:目的:评估经皮腔内血管成形术(PTA)后血管内支架在治疗血液透析移植物中的破裂性。材料与方法:自1994年2月1日至1997年8月1日,对277例患者进行了683例与血液透析相关的血管成形术,以治疗血栓形成或功能不佳的聚四氟乙烯(PTFE)血液透析桥移植物。在这些程序中的每一个中,都进行了静脉吻合或流出静脉的血管成形术。这项研究是一项回顾性回顾,旨在分析未暴露的血管内支架以治疗PTA后的破裂。结果:使用未覆盖的金属支架治疗了14处破裂。从技术上讲,在14例患者中有11例成功置入支架,在14例患者中有11例取得了临床成功。通过Kaplan-Meier生命表分析计算30、60、90和120天的主要通畅率;分别是63%,54%,46%和46%。在60天,120天和180天时的二次通畅率分别为85%,75%和75%。没有并发症归因于支架置入。由于除破裂以外的其他原因,结果可与放置支架的结果相媲美,并支持其用于此适应症的功效。结论:血管内支架置入术是挽救在血液透析移植物治疗过程中发生的血管成形术引起的破裂的一种安全有效的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号